An authorized generic of Exalgo was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (hydromorphone hydrochloride) is available.
Source: FDA, updated October 30, 2026
How to pay the least
Ask for the cash price
Generic hydromorphone
No pharmacy we check posts a price for it.
- Ask your pharmacy for the cash price of generic hydromorphone.Find pharmacies near you
- Ask one or two other pharmacies too. Cash prices for the same generic can differ a lot from store to store.
A regular generic has the same active ingredient as Exalgo, and the FDA requires it to work the same way.
Compare every option
Question
Brand nameExalgo
Authorized generichydromorphone
Regular generichydromorphone
What you’d pay
Not soldNo longer sold
Not soldNo longer sold
Cash priceAsk the pharmacy
Same as Exalgo?
–
–
Same active ingredientFillers and dyes can differ
Details for each option
Details for
Brand nameNot sold
Exalgo itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.
Authorized genericNot sold now
Regular genericWho makes it
3 companies sell a generic of Exalgo that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
-
Camber Pharmaceuticals8 mg, 12 mg, 16 mg, 32 mg
Made by Ascent Pharmaceuticals
Product page on camberpharma.com
How it looks, what’s in it, NDCs
8 mg Light pink to pink, round, 7 mm, marked “266”
Package NDC Bottle of 100 31722-119-01 12 mg Light yellow to yellow, round, 8 mm, marked “267”
Package NDC Bottle of 100 31722-120-01 16 mg Light beige to beige, round, 9 mm, marked “268”
Package NDC Bottle of 100 31722-121-01 32 mg White to off white, round, 9 mm, marked “269”
Package NDC Bottle of 100 31722-122-01 Inactive ingredients: polyethylene oxide 200000, povidone, butylated hydroxytoluene, isopropyl alcohol, magnesium stearate, sodium chloride, hypromellose, ferric oxide yellow, acetone, cellulose acetate, polyethylene glycol, titanium dioxide, polysorbate 80, talc, ferrosoferric oxide, propylene glycol
-
Padagis8 mg, 12 mg, 16 mg
How it looks, what’s in it, NDCs
8 mg Dark Beige, round, 7 mm, marked “P293 / 8”
Package NDC Bottle of 100 0574-0293-01 12 mg White, round, 8 mm, marked “P294 / 12”
Package NDC Bottle of 100 0574-0294-01 16 mg Light Beige, round, 9 mm, marked “P295 / 16”
Package NDC Bottle of 100 0574-0295-01 Inactive ingredients: microcrystalline cellulose, mannitol, silicon dioxide, magnesium stearate, ethylcellulose (100 mpa.s), povidone k30, triethyl citrate, ammonio methacrylate copolymer type a, talc, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, hypromellose 2910 (3 mpa.s), hypromellose 2910 (6 mpa.s), polyethylene glycol 400, propylene glycol, shellac, titanium dioxide, polysorbate 80
-
Trigen Laboratories8 mg, 12 mg, 16 mg, 32 mg
Has lactose · Has dyes: FD&C Red No. 40 aluminum lake, D&C Yellow No. 10 aluminum lake, FD&C Yellow No. 6 aluminum lake · Made by Osmotica Pharmaceutical
How it looks, what’s in it, NDCs
8 mg Pink, round, 9 mm, marked “OS211”
Package NDC Bottle of 100 13811-701-10 12 mg Dark, round, 9 mm, marked “OS212”
Package NDC Bottle of 100 13811-702-10 16 mg Yellow, round, 10 mm, marked “OS213”
Package NDC Bottle of 100 13811-703-10 32 mg White, round, 10 mm, marked “OS214”
Package NDC Bottle of 100 13811-704-10 Inactive ingredients: cellulose acetate, ferrosoferric oxide, hypromellose 2910 (5 mpa.s), lactose monohydrate, magnesium stearate, polyethylene glycol, sodium chloride, titanium dioxide, triacetin, silicon dioxide, FD&C Red No. 40 aluminum lake, polyethylene oxide 200000, hypromellose 2208 (100 mpa.s), polyethylene glycol 7000000, ferric oxide yellow, D&C Yellow No. 10 aluminum lake, FD&C Yellow No. 6 aluminum lake
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
What it’s used for
What the FDA label says
Hydromorphone hydrochloride extended-release tablets are an opioid agonist indicated in opioid-tolerant patients for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids.
Patients considered opioid tolerant are those who are taking, for one week or longer, at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, 25 mg oral oxymorphone per day, 60 mg oral hydrocodone per day, or an equianalgesic dose of another opioid.
Limitations of Use:
- Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including hydromorphone hydrochloride extended-release tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
- Hydromorphone hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic.
Source: the FDA label for Hydromorphone Hydrochloride (Trigen Laboratories, LLC), December 25, 2025. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/exalgo/